Transport of fragile X mental retardation protein via granules in neurites of PC12 cells

Mol Cell Biol. 2002 Dec;22(23):8332-41. doi: 10.1128/MCB.22.23.8332-8341.2002.

Abstract

Lack of fragile X mental retardation protein (FMRP) causes fragile X syndrome, a common form of inherited mental retardation. FMRP is an RNA binding protein thought to be involved in translation efficiency and/or trafficking of certain mRNAs. Recently, a subset of mRNAs to which FMRP binds with high affinity has been identified. These FMRP-associated mRNAs contain an intramolecular G-quartet structure. In neurons, dendritic mRNAs are involved in local synthesis of proteins in response to synaptic activity, and this represents a mechanism for synaptic plasticity. To determine the role of FMRP in dendritic mRNA transport, we have generated a stably FMR1-enhanced green fluorescent protein (EGFP)-transfected PC12 cell line with an inducible expression system (Tet-On) for regulated expression of the FMRP-GFP fusion protein. After doxycycline induction, FMRP-GFP was localized in granules in the neurites of PC12 cells. By using time-lapse microscopy, the trafficking of FMRP-GFP granules into the neurites of living PC12 cells was demonstrated. Motile FMRP-GFP granules displayed two types of movements: oscillatory (bidirectional) and unidirectional anterograde. The average velocity of the granules was 0.19 micro m/s with a maximum speed of 0.71 micro m/s. In addition, we showed that the movement of FMRP-GFP labeled granules into the neurites was microtubule dependent. Colocalization studies further showed that the FMRP-GFP labeled granules also contained RNA, ribosomal subunits, kinesin heavy chain, and FXR1P molecules. This report is the first example of trafficking of RNA-containing granules with FMRP as a core constituent in living PC12 cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Antineoplastic Agents / pharmacology
  • Cytochalasin D / pharmacology
  • Cytoplasmic Granules / chemistry
  • Cytoplasmic Granules / metabolism*
  • Doxycycline / pharmacology
  • Fragile X Mental Retardation Protein
  • Fragile X Syndrome / metabolism
  • Gene Expression Regulation
  • Green Fluorescent Proteins
  • Humans
  • Indicators and Reagents / metabolism
  • Intellectual Disability
  • Luminescent Proteins / genetics
  • Luminescent Proteins / metabolism
  • Microscopy, Confocal
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Neurites / metabolism*
  • Nocodazole / pharmacology
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • PC12 Cells
  • Protein Transport
  • RNA, Messenger / metabolism
  • RNA-Binding Proteins / metabolism
  • Rats
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Time Factors

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • FMR1 protein, human
  • Fmr1 protein, rat
  • Indicators and Reagents
  • Luminescent Proteins
  • Nerve Tissue Proteins
  • Nucleic Acid Synthesis Inhibitors
  • RNA, Messenger
  • RNA-Binding Proteins
  • Recombinant Fusion Proteins
  • Fragile X Mental Retardation Protein
  • Green Fluorescent Proteins
  • Cytochalasin D
  • Doxycycline
  • Nocodazole